Prediabetes: a high-risk state for diabetes development

2006 2011, Diagnosis and classification of diabetes mellitus, Diabetes Care, 34, S62 2009, International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care, 32, 1327, 10.2337/dc09-9033 Balion, 2007, Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review, Clin Chem Lab Med, 45, 1180, 10.1515/CCLM.2007.505 2003, Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts, Diabetes Care, 26, 61, 10.2337/diacare.26.1.61 Buijsse, 2011, Risk assessment tools for identifying individuals at risk of developing type 2 diabetes, Epidemiol Rev, 33, 46, 10.1093/epirev/mxq019 Danaei, 2011, National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants, Lancet, 378, 31, 10.1016/S0140-6736(11)60679-X Katikireddi, 2011, Is there a divergence in time trends in the prevalence of impaired glucose tolerance and diabetes? A systematic review in south Asian populations, Int J Epidemiol, 40, 1542, 10.1093/ije/dyr159 2011 Cowie, 2009, Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006, Diabetes Care, 32, 287, 10.2337/dc08-1296 2011 Forouhi, 2007, Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990–2000, Diabet Med, 24, 200, 10.1111/j.1464-5491.2007.02068.x Nathan, 2007, Impaired fasting glucose and impaired glucose tolerance: implications for care, Diabetes Care, 30, 753, 10.2337/dc07-9920 Gerstein, 2007, Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies, Diabetes Res Clin Pract, 78, 305, 10.1016/j.diabres.2007.05.004 2009, 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study, Lancet, 374, 1677, 10.1016/S0140-6736(09)61457-4 Yeboah, 2011, Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 58, 140, 10.1016/j.jacc.2011.03.025 Heianza, 2011, HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study, Lancet, 378, 147, 10.1016/S0140-6736(11)60472-8 Zhang, 2010, A1C level and future risk of diabetes: a systematic review, Diabetes Care, 33, 1665, 10.2337/dc09-1939 Li, 2008, The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study, Lancet, 371, 1783, 10.1016/S0140-6736(08)60766-7 Kim, 2002, Gestational diabetes and the incidence of type 2 diabetes: a systematic review, Diabetes Care, 25, 1862, 10.2337/diacare.25.10.1862 Feig, 2008, Risk of development of diabetes mellitus after diagnosis of gestational diabetes, CMAJ, 179, 229, 10.1503/cmaj.080012 Lauenborg, 2004, Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population, Diabetes Care, 27, 1194, 10.2337/diacare.27.5.1194 Bellamy, 2009, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis, Lancet, 373, 1773, 10.1016/S0140-6736(09)60731-5 2006, Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, Lancet, 368, 1096, 10.1016/S0140-6736(06)69420-8 Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512 Ramachandran, 2006, The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1), Diabetologia, 49, 289, 10.1007/s00125-005-0097-z Torgerson, 2004, XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients, Diabetes Care, 27, 155, 10.2337/diacare.27.1.155 Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801 DeFronzo, 2011, Pioglitazone for diabetes prevention in impaired glucose tolerance, N Engl J Med, 364, 1104, 10.1056/NEJMoa1010949 Noble, 2011, Risk models and scores for type 2 diabetes: systematic review, BMJ, 343, d7163, 10.1136/bmj.d7163 Tirosh, 2005, Normal fasting plasma glucose levels and type 2 diabetes in young men, N Engl J Med, 353, 1454, 10.1056/NEJMoa050080 Rathmann, 2010, Prediction models for incident type 2 diabetes mellitusin the older population: KORA S4/F4 cohort study, Diabet Med, 27, 1116, 10.1111/j.1464-5491.2010.03065.x Wilson, 2007, Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study, Arch Intern Med, 167, 1068, 10.1001/archinte.167.10.1068 Carstensen, 2010, Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study, Diabetes, 59, 1222, 10.2337/db09-1199 Sattar, 2007, Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor, Diabetes, 56, 984, 10.2337/db06-1256 Tabák, 2009, Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study, Lancet, 373, 2215, 10.1016/S0140-6736(09)60619-X Abdul-Ghani, 2006, Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose, Diabetes Care, 29, 1130, 10.2337/dc05-2179 Ferrannini, 2011, Pathophysiology of prediabetes, Med Clin North Am, 95, 327, 10.1016/j.mcna.2010.11.005 DeFronzo, 2009, Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus, Diabetes, 58, 773, 10.2337/db09-9028 Ferrannini, 2004, Mode of onset of type 2 diabetes from normal or impaired glucose tolerance, Diabetes, 53, 160, 10.2337/diabetes.53.1.160 Mason, 2007, Progression to type 2 diabetes characterized by moderate then rapid glucose increases, Diabetes, 56, 2054, 10.2337/db07-0053 Gastaldelli, 2004, Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study, Diabetologia, 47, 31, 10.1007/s00125-003-1263-9 Weir, 2004, Five stages of evolving beta-cell dysfunction during progression to diabetes, Diabetes, 53, S16, 10.2337/diabetes.53.suppl_3.S16 Polonsky, 1988, Quantitative study of insulin secretion and clearance in normal and obese subjects, J Clin Invest, 81, 435, 10.1172/JCI113338 DeFronzo, 2011, Preservation of beta-cell function: the key to diabetes prevention, J Clin Endocrinol Metab, 96, 2354, 10.1210/jc.2011-0246 Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 Kahn, 2003, The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes, Diabetologia, 46, 3, 10.1007/s00125-002-1009-0 Ferrannini, 2007, Insulin resistance, insulin response, and obesity as indicators of metabolic risk, J Clin Endocrinol Metab, 92, 2885, 10.1210/jc.2007-0334 Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes, 52, 102, 10.2337/diabetes.52.1.102 Kanat, 2012, Distinct beta-cell defects in impaired fasting glucose and impaired glucose tolerance, Diabetes, 61, 447, 10.2337/db11-0995 Gabir, 2000, Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes, Diabetes Care, 23, 1113, 10.2337/diacare.23.8.1113 Hoehner, 2002, Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project, J Am Soc Nephrol, 13, 1626, 10.1097/01.ASN.0000015762.92814.85 Metcalf, 1993, Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity, Diabetes Care, 16, 1485, 10.2337/diacare.16.11.1485 Plantinga, 2010, Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes, Clin J Am Soc Nephrol, 5, 673, 10.2215/CJN.07891109 Xu, 2009, Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population, Diabetologia, 52, 1511, 10.1007/s00125-009-1386-8 Fujita, 1999, Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance, Diabetes Care, 22, 823, 10.2337/diacare.22.5.823 Hermans, 2007, Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study, J Am Soc Nephrol, 18, 1942, 10.1681/ASN.2006111217 Melsom, 2011, Impaired fasting glucose is associated with renal hyperfiltration in the general population, Diabetes Care, 34, 1546, 10.2337/dc11-0235 Fox, 2005, Glycemic status and development of kidney disease: the Framingham Heart Study, Diabetes Care, 28, 2436, 10.2337/diacare.28.10.2436 Thomas, 2011, Metabolic syndrome and kidney disease: a systematic review and meta-analysis, Clin J Am Soc Nephrol, 6, 2364, 10.2215/CJN.02180311 Tesfaye, 2010, Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments, Diabetes Care, 33, 2285, 10.2337/dc10-1303 Wu, 2007, Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose, J Clin Endocrinol Metab, 92, 3885, 10.1210/jc.2006-2175 Gerritsen, 2000, Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study, Diabetologia, 43, 561, 10.1007/s001250051344 Singh, 2000, Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study), Am J Cardiol, 86, 309, 10.1016/S0002-9149(00)00920-6 Schroeder, 2005, Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study, Diabetes Care, 28, 668, 10.2337/diacare.28.3.668 Grover, 2006, The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease, Arch Intern Med, 166, 213, 10.1001/archinte.166.2.213 Putz, 2009, Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance, Diabetes Care, 32, 181, 10.2337/dc08-1406 Ziegler, 2008, Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3, Diabetes Care, 31, 464, 10.2337/dc07-1796 Ylitalo, 2011, Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001–2004, Diabetes Care, 34, 1642, 10.2337/dc10-2150 Bruce, 2008, Prevalence and risk factors for neuropathy in a Canadian First Nation community, Diabetes Care, 31, 1837, 10.2337/dc08-0278 Smith, 2006, Lifestyle intervention for pre-diabetic neuropathy, Diabetes Care, 29, 1294, 10.2337/dc06-0224 Grandinetti, 2007, Impaired glucose tolerance is associated with postganglionic sudomotor impairment, Clin Auton Res, 17, 231, 10.1007/s10286-007-0426-z Hoffman-Snyder, 2006, Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy, Arch Neurol, 63, 1075, 10.1001/archneur.63.8.noc50336 Smith, 2004, The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy, Arch Intern Med, 164, 1021, 10.1001/archinte.164.9.1021 Singleton, 2001, Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy, Diabetes Care, 24, 1448, 10.2337/diacare.24.8.1448 Nebuchennykh, 2008, Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series, Eur J Neurol, 15, 810, 10.1111/j.1468-1331.2008.02197.x Smith, 2001, Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy, Neurology, 57, 1701, 10.1212/WNL.57.9.1701 Sumner, 2003, The spectrum of neuropathy in diabetes and impaired glucose tolerance, Neurology, 60, 108, 10.1212/WNL.60.1.108 Algvere, 1985, Retinal microangiopathy and pigment epithelial lesions in subjects with normal, borderline, and decreased oral glucose tolerance, Br J Ophthalmol, 69, 416, 10.1136/bjo.69.6.416 Tapp, 2008, Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study, Diabetes Care, 31, 1349, 10.2337/dc07-1707 Nguyen, 2007, Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications, Diabetes Care, 30, 2 708, 10.2337/dc07-0732 Wong, 2002, Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons, JAMA, 287, 2528, 10.1001/jama.287.19.2528 Nguyen, 2008, Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study, Diabetes, 57, 536, 10.2337/db07-1376 2010, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies, Lancet, 375, 2215, 10.1016/S0140-6736(10)60484-9 Seshasai, 2011, Diabetes mellitus, fasting glucose, and risk of cause-specific death, N Engl J Med, 364, 829, 10.1056/NEJMoa1008862 Barr, 2007, Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab), Circulation, 116, 151, 10.1161/CIRCULATIONAHA.106.685628 Brunner, 2006, Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study, Diabetes Care, 29, 26, 10.2337/diacare.29.01.06.dc05-1405 2001, Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria, Arch Intern Med, 161, 397, 10.1001/archinte.161.3.397 Sarwar, 2010, Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review, PLoS Med, 7, e1000278, 10.1371/journal.pmed.1000278 Hamman, 2006, Effect of weight loss with lifestyle intervention on risk of diabetes, Diabetes Care, 29, 2102, 10.2337/dc06-0560 Saito, 2011, Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial, Arch Intern Med, 171, 1352, 10.1001/archinternmed.2011.275 Snehalatha, 2009, Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1), Diabetes Care, 32, 1796, 10.2337/dc09-0676 Kitabchi, 2005, Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin, Diabetes, 54, 2404, 10.2337/diabetes.54.8.2404 Salpeter, 2008, Meta-analysis: metformin treatment in persons at risk for diabetes mellitus, Am J Med, 121, 149, 10.1016/j.amjmed.2007.09.016 Nathan, 2009, Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetologia, 52, 17, 10.1007/s00125-008-1157-y Lilly, 2009, Treating prediabetes with metformin: systematic review and meta-analysis, Can Fam Physician, 55, 363 Dagenais, 2008, Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, Diabetes Care, 31, 1007, 10.2337/dc07-1868 Piccinni, 2011, Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting, Diabetes Care, 34, 1369, 10.2337/dc10-2412 Tseng, 2012, Pioglitazone and bladder cancer: a population-based study of Taiwanese, Diabetes Care, 35, 278, 10.2337/dc11-1449 Ramachandran, 2009, Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2), Diabetologia, 52, 1019, 10.1007/s00125-009-1315-x Zinman, 2010, Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study, Lancet, 376, 103, 10.1016/S0140-6736(10)60746-5 Kawamori, 2009, Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance, Lancet, 373, 1607, 10.1016/S0140-6736(09)60222-1 Chiasson, 2002, Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial, Lancet, 359, 2072, 10.1016/S0140-6736(02)08905-5 Chiasson, 2003, Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial, JAMA, 290, 486, 10.1001/jama.290.4.486 Astrup, 2011, Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide, Int J Obes (Lond) Rosenstock, 2010, Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes, Diabetes Care, 33, 1173, 10.2337/dc09-1203 Astrup, 2009, Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study, Lancet, 374, 1606, 10.1016/S0140-6736(09)61375-1 Holman, 2010, Effect of nateglinide on the incidence of diabetes and cardiovascular events, N Engl J Med, 362, 1463, 10.1056/NEJMoa1001122 Heymsfield, 2000, Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults, Arch Intern Med, 160, 1321, 10.1001/archinte.160.9.1321 Wan, 2010, Regression to normoglycaemia by fenofibrate in pre-diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial, Diabet Med, 27, 1312, 10.1111/j.1464-5491.2010.03107.x Al-Mallah, 2010, Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis, Cardiol J, 17, 448 McMurray, 2010, Effect of valsartan on the incidence of diabetes and cardiovascular events, N Engl J Med, 362, 1477, 10.1056/NEJMoa1001121 Bosch, 2006, Effect of ramipril on the incidence of diabetes, N Engl J Med, 355, 1551, 10.1056/NEJMoa065061 Sjöström, 2004, Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery, N Engl J Med, 351, 2683, 10.1056/NEJMoa035622 Sjöström, 2012, Bariatric surgery and long-term cardiovascular events, JAMA, 307, 56, 10.1001/jama.2011.1914 Hopper, 2011, Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials, Eur J Cardiovasc Prev Rehabil, 18, 813, 10.1177/1741826711421687 Lindström, 2006, Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study, Lancet, 368, 1673, 10.1016/S0140-6736(06)69701-8 Gerstein, 2011, Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes, Diabetologia, 54, 487, 10.1007/s00125-010-1985-4 Gong, 2011, Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study, Diabetologia, 54, 300, 10.1007/s00125-010-1948-9 Perreault, 2012, Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study, Lancet, 10.1016/S0140-6736(12)60525-X Eriksson, 1998, No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise, Diabetologia, 41, 1010, 10.1007/s001250051024